Lamdong Pharmaceutical JSC (HNX:LDP)
Vietnam · Delayed Price · Currency is VND 8,000.00
+100.00 (1.27%)
At close: Aug 12, 2026
HNX:LDP Ratios and Metrics
Market cap in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 149,825 | 148,053 | 129,572 | 201,980 | 66,056 | 476,368 | |
Market Cap Growth | 3.05% | 14.26% | -35.85% | 205.77% | -86.13% | 180.37% |
Enterprise Value | 185,059 | 188,307 | 161,439 | 252,243 | 161,527 | 488,077 |
Last Close Price | 8000.00 | 11100.00 | 10200.00 | 15900.00 | 5200.00 | 37500.00 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 4.78 | 5.18 | 18.73 | - | - | 12.58 |
PS Ratio | 0.57 | 0.61 | 0.59 | 1.09 | 0.35 | 2.94 |
PB Ratio | 0.78 | 0.77 | 1.31 | 2.19 | 0.59 | 3.11 |
P/TBV Ratio | 0.78 | 0.77 | 1.31 | 2.19 | 0.59 | 3.12 |
P/FCF Ratio | - | - | 22.21 | 33.79 | - | 22.27 |
P/OCF Ratio | 35.71 | 42.89 | 14.78 | 33.46 | - | 16.38 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.71 | 0.77 | 0.74 | 1.36 | 0.86 | 3.02 |
EV/EBITDA Ratio | 6.23 | 8.15 | 7.98 | - | - | - |
EV/EBIT Ratio | 7.45 | 10.79 | 12.16 | - | - | - |
EV/FCF Ratio | - | - | 27.67 | 42.20 | - | 22.82 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.32 | 0.30 | 0.55 | 0.71 | 0.63 | 0.21 |
Debt / EBITDA Ratio | 2.09 | 2.46 | 2.72 | - | - | - |
Debt / FCF Ratio | - | - | 9.43 | 11.04 | - | 1.51 |
Net Debt / Equity Ratio | 0.18 | 0.19 | 0.38 | 0.50 | 0.47 | -0.21 |
Net Debt / EBITDA Ratio | 1.19 | 1.56 | 1.87 | -11.13 | -3.20 | 4.08 |
Net Debt / FCF Ratio | -0.61 | -0.61 | 6.49 | 7.65 | -1.12 | -1.54 |
Asset Turnover | 0.99 | 0.95 | 1.09 | 0.88 | 0.84 | - |
Inventory Turnover | 2.87 | 3.12 | 3.54 | 3.18 | 2.71 | - |
Quick Ratio | 0.58 | 0.58 | 0.43 | 0.43 | 0.45 | 1.52 |
Current Ratio | 2.14 | 2.19 | 1.48 | 1.39 | 1.40 | 2.47 |
Return on Equity (ROE) | 18.70% | 19.64% | 7.22% | -19.63% | -29.26% | - |
Return on Assets (ROA) | 5.85% | 4.24% | 4.13% | -3.65% | -7.12% | - |
Return on Invested Capital (ROIC) | 9.89% | 9.53% | 9.65% | -8.15% | -17.73% | -12.77% |
Return on Capital Employed (ROCE) | 12.70% | 9.00% | 13.10% | -13.10% | -22.10% | -12.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 18.74% | 19.29% | 5.34% | -9.95% | -58.88% | 7.95% |
FCF Yield | -39.03% | -40.25% | 4.50% | 2.96% | -70.73% | 4.49% |
Buyback Yield / Dilution | -28.75% | -10.75% | 0.00% | -0.01% | 0.02% | -62.22% |